• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Basic research for the pathogenesis of idiopathic epiretinal membranes

Research Project

  • PDF
Project/Area Number 15K10910
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Ophthalmology
Research InstitutionOsaka Medical College

Principal Investigator

Ikeda Tsunehiko  大阪医科大学, 医学部, 教授 (70222891)

Co-Investigator(Kenkyū-buntansha) 奥 英弘  大阪医科大学, 医学部, 准教授 (90177163)
Co-Investigator(Renkei-kenkyūsha) Takai Shinji  大阪医科大学, 医学部, 教授 (80288703)
Research Collaborator Morishita Seita  
Horie Taeko  
Project Period (FY) 2015-04-01 – 2018-03-31
Keywords黄斑上膜 / 黄斑円孔 / セリンプロテアーゼ / トリプターゼ / キマーゼ / 抗2型コラーゲン抗体 / ニューステロイド / 免疫染色
Outline of Final Research Achievements

To investigate the pathogenesis of idiopathic epiretinal membrane (ERM) from a biochemical perspective, the relationships between ERMs and tryptase activity and anti-type II collagen antibodies were investigated. Vitreous samples for measurement of tryptase activity were obtained from patients who underwent a vitrectomy for idiopathic macular hole (MH), proliferative diabetic retinopathy (PDR), ERM, and rhegmatogenous retinal detachment (RD). Anti-type II collagen antibodies were measured in serum obtained from the patients with ERM, PDR, and RD. Vitreal tryptase activity was significantly higher in MH and ERM than in PDR and RD. The serum levels of anti-type II collagen antibodies were significantly higher in the ERM and PDR than in RD. In the pathogenesis of ERM, increased vitreal tryptase activity may be involved in tissue fibrosis, and elevated serum anti-type II collagen antibodies may lead to an immune response at the vitreoretinal interface, thus resulting in membrane formation.

Free Research Field

眼科学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi